Literature DB >> 11669629

Covalent linkage of prosthetic heme to CYP4 family P450 enzymes.

K R Henne1, K L Kunze, Y M Zheng, P Christmas, R J Soberman, A E Rettie.   

Abstract

An extensive body of research on the structural properties of cytochrome P450 enzymes has established that these proteins possess a b-type heme prosthetic group which is noncovalently bound at the active site. Coordinate, electrostatic, and hydrogen bond interactions between the protein backbone and heme functional groups are readily overcome upon mild acid treatment of the enzyme, which releases free heme from the protein. In the present study, we have used a combination of HPLC, LC/ESI-MS, and SDS-PAGE techniques to demonstrate that members of the mammalian CYP4B, CYP4F, and CYP4A subfamilies bind their heme in an unusually tight manner. HPLC chromatography of CYP4B1 on a POROS R2 column under mild acidic conditions caused dissociation of less than one-third of the heme from the protein. Moreover, heme was not substantially removed from CYP4B1 under electrospray or electrophoresis conditions that readily release the prosthetic group from other non-CYP4 P450 isoforms. This was evidenced by an intact protein mass value of 59,217 +/- 3 amu for CYP4B1 (i.e., apoprotein plus heme) and extensive staining of this approximately 60 kDa protein with tetramethylbenzidine/H(2)O(2) following SDS-PAGE. In addition, treatment of CYP4B1, CYP4F3, and CYP4A5/7 with strong base generated a new, chromatographically distinct, polar heme species with a mass of 632.3 amu rather than 616.2 amu. This mass shift is indicative of the incorporation of an oxygen atom into the heme nucleus and is consistent with the presence of a novel covalent ester linkage between the protein backbone of the CYP4 family of mammalian P450s and their heme catalytic center.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11669629     DOI: 10.1021/bi011171z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

Review 1.  Structural control of cytochrome P450-catalyzed ω-hydroxylation.

Authors:  Jonathan B Johnston; Hugues Ouellet; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2010-08-19       Impact factor: 4.013

2.  Contribution of 20-HETE to augmented myogenic constriction in coronary arteries of endothelial NO synthase knockout mice.

Authors:  An Huang; Dong Sun; Changdong Yan; John R Falck; Gabor Kaley
Journal:  Hypertension       Date:  2005-07-25       Impact factor: 10.190

3.  Noncovalent interactions dominate dynamic heme distortion in cytochrome P450 4B1.

Authors:  Gareth K Jennings; Mei-Hui Hsu; Lisa S Shock; Eric F Johnson; John C Hackett
Journal:  J Biol Chem       Date:  2018-06-01       Impact factor: 5.157

4.  Ligand characterization of CYP4B1 isoforms modified for high-level expression in Escherichia coli and HepG2 cells.

Authors:  Katharina Roellecke; Vera D Jäger; Veselin H Gyurov; John P Kowalski; Stephanie Mielke; Allan E Rettie; Helmut Hanenberg; Constanze Wiek; Marco Girhard
Journal:  Protein Eng Des Sel       Date:  2017-03-01       Impact factor: 1.650

5.  Functional expression and characterization of cytochrome P450 52A21 from Candida albicans.

Authors:  Donghak Kim; Max J Cryle; James J De Voss; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2007-03-16       Impact factor: 4.013

6.  Novel insights into oxidation of fatty acids and fatty alcohols by cytochrome P450 monooxygenase CYP4B1.

Authors:  Florian A Thesseling; Michael C Hutter; Constanze Wiek; John P Kowalski; Allan E Rettie; Marco Girhard
Journal:  Arch Biochem Biophys       Date:  2019-12-01       Impact factor: 4.013

7.  Metabolism of Benzalkonium Chlorides by Human Hepatic Cytochromes P450.

Authors:  Ryan P Seguin; Josi M Herron; Vanessa A Lopez; Joseph L Dempsey; Libin Xu
Journal:  Chem Res Toxicol       Date:  2019-12-03       Impact factor: 3.739

8.  Glutamine-451 Confers Sensitivity to Oxidative Inhibition and Heme-Thiolate Sulfenylation of Cytochrome P450 4B1.

Authors:  Matthew E Albertolle; Hyun D Song; Clayton J Wilkey; Jere P Segrest; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2019-02-11       Impact factor: 3.739

Review 9.  CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities.

Authors:  Katheryne Z Edson; Allan E Rettie
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

10.  Mechanism of formation of the ester linkage between heme and Glu310 of CYP4B1: 18O protein labeling studies.

Authors:  Brian R Baer; Kent L Kunze; Allan E Rettie
Journal:  Biochemistry       Date:  2007-09-19       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.